Semler Scientific, Inc. Q3 FY2024 Earnings Call

· Earnings call transcript and AI-powered summary

  • Total Revenue: $13.5 million, a decline of 17% from Q3 2023.
  • Income from Operations: $5.1 million, down from $6.3 million in Q3 2023.
  • Net Income: $5.6 million ($0.80 per basic share, $0.72 per diluted share), slightly higher than Q3 2023 ($5.5 million, $0.82 basic, $0.71 diluted).
  • Operating Expenses: $8.4 million, a 16% decrease YoY, reflecting tight cost controls.
  • Cash Holdings: $6.7 million (including cash, cash equivalents, and restricted cash as of Sept 30, 2024).

Bitcoin Treasury Strategy

  • Semler has adopted Bitcoin as its primary treasury reserve asset.
  • As of November 5, 2024, holds 1,058 Bitcoins.
  • Total Q3 Bitcoin purchases: 142 Bitcoins for $8.4 million.
  • Post-quarter purchases: 40 Bitcoins for $2.6 million.
  • Total cumulative Bitcoin investment: $71 million.
  • ATM (At-The-Market) program initiated with up to $50 million equity issuance potential.
  • Q3 ATM activity: Sold ~87,000 shares for $2.5 million net proceeds, used for Bitcoin acquisitions.

Core Medical Business Update

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Good afternoon, everyone, and welcome to the Semler Scientific Third Quarter 2024 Financial Results Conference Call. All participants will be in a listen only mode. After today's prepared remarks, as time permits, management will take questions submitted prior to this call via email. Please note, this event is being recorded. Before we begin, Semler Scientific needs to remind you that certain comments made during this call may constitute forward-looking statements and are made pursuant to and within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. These include statements regarding the expectations for expansion of the business, the development and marketing of additional products, including receipt and timing of an additional 510(k) clearance for QuantaFlo and our recently adopted Bitcoin treasury strategy that plans to acquire additional Bitcoin. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from such statements. Those risks and uncertainties are described in the press release and our SEC filings. The forward-looking statements made today are as of the date of this call. The company does not undertake any obligation to update forward-looking statements. If you do not have a copy of today's release, you may obtain one by visiting the Investor Relations page of the website at semlerscientific.com. Now I'd l

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional